PCFFS
LSTA icon

Pacific Center for Financial Services’s Lisata Therapeutics LSTA Stock Holding History

Pacific Center for Financial Services’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8
Closed -$26 – 412
2023
Q1 		$26 Buy
+8
New +$27 ﹤0.01% 400

Other funds holding LSTA

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CW
Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return

Pacific Center for Financial Services's LSTA Position: Q2 2023 in Review

Pacific Center for Financial Services sold out of Lisata Therapeutics (LSTA) in Q2 2023, closing a stake of 8 shares — an estimated $26 sold.

Pacific Center for Financial Services first reported a position in LSTA in Q1 2023 and held it in 1 quarter. The position peaked at $26 in Q1 2023. 22 funds tracked by Wall St. Rank hold LSTA as of Q2 2023.

  • Pacific Center for Financial Services reported no remaining Lisata Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Pacific Center for Financial Services sold 8 Lisata Therapeutics shares in Q2 2023, an estimated $26.
  • Pacific Center for Financial Services first reported a position in Lisata Therapeutics in Q1 2023 and held it in 1 quarter.
  • Pacific Center for Financial Services's Lisata Therapeutics position peaked at $26 in Q1 2023.
  • 22 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2023.

Based on Pacific Center for Financial Services's 13F filing for Q2 2023, filed 10 Aug 2023.